MUTZ-3 derived Langerhans cells in human skin equivalents show differential migration and phenotypic plasticity after allergen or irritant exposure  by Kosten, Ilona J. et al.
Toxicology and Applied Pharmacology 287 (2015) 35–42
Contents lists available at ScienceDirect
Toxicology and Applied Pharmacology
j ourna l homepage: www.e lsev ie r .com/ locate /ytaapMUTZ-3 derived Langerhans cells in human skin equivalents show
differential migration and phenotypic plasticity after allergen or
irritant exposureIlona J. Kosten a, Sander W. Spiekstra a, Tanja D. de Gruijl b, Susan Gibbs a,c,⁎
a Department of Dermatology, VU University Medical Center, Amsterdam, The Netherlands
b Department of Dermatology Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands
c Department of Oral Cell Biology, Academic Center for Dentistry (ACTA), Amsterdam, The NetherlandsAbbreviations:ACD, allergic contact dermatitis; CFSE, c
ester; DC, dendritic cell; FACS, ﬂuorescence-activated ce
FITC, ﬂuorescein isothiocyanate; ICD, irritant contact de
Langerhans cell; MUTZ-LC, MUTZ-3 derived Langerha
hexahydrate; PE, phycoerythrin; PerCP, peridinin chlo
dodecyl sulfate; SE, skin equivalent; TGF-β, tumor growth fa
factor alpha.
⁎ Corresponding author at: Department of Oral Cell Bi
Center for Dentistry (ACTA) GustavMahlerlaan 3004, 1081H
E-mail address: s.gibbs@acta.nl (S. Gibbs).
http://dx.doi.org/10.1016/j.taap.2015.05.017
0041-008X/© 2015 The Authors. Published by Elsevier Inca b s t r a c ta r t i c l e i n f oArticle history:
Received 2 March 2015
Revised 9 May 2015
Accepted 19 May 2015
Available online 29 May 2015
Keywords:
Langerhans cell
Macrophage
Skin equivalent
Chemokine
Allergen
IrritantAfter allergen or irritant exposure, Langerhans cells (LC) undergo phenotypic changes and exit the epidermis. In
this study we describe the unique ability of MUTZ-3 derived Langerhans cells (MUTZ-LC) to display similar
phenotypic plasticity as their primary counterparts when incorporated into a physiologically relevant
full-thickness skin equivalentmodel (SE-LC).We describe differences and similarities in themechanisms regulating
LC migration and plasticity upon allergen or irritant exposure. The skin equivalent consisted of a reconstructed
epidermis containing primary differentiated keratinocytes and CD1a+ MUTZ-LC on a primary ﬁbroblast-
populated dermis. Skin equivalents were exposed to a panel of allergens and irritants. Topical exposure to
sub-toxic concentrations of allergens (nickel sulfate, resorcinol, cinnamaldehyde) and irritants (Triton X-100,
SDS, Tween 80) resulted in LC migration out of the epidermis and into the dermis. Neutralizing antibody to
CXCL12 blocked allergen-induced migration, whereas anti-CCL5 blocked irritant-induced migration. In contrast
to allergen exposure, irritant exposure resulted in cells within the dermis becoming CD1a−/CD14+/CD68+
which is characteristic of a phenotypic switch of MUTZ-LC to a macrophage-like cell in the dermis. This pheno-
typic switch was blocked with anti-IL-10. Mechanisms previously identiﬁed as being involved in LC activation
and migration in native human skin could thus be reproduced in the in vitro constructed skin equivalent
model containing functional LC. This model therefore provides a unique and relevant research tool to study
human LC biology in situ under controlled in vitro conditions, and will provide a powerful tool for hazard identi-
ﬁcation, testing novel therapeutics and identifying new drug targets.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
All skin diseases have an underlying immune component. In order to
investigate human skin disease, physiologically relevant and immune
competent humanmodelsmimicking the characteristic 3D tissue context
of skin are therefore required. Although animalmodels, in particularmice,
are used extensively, misleading conclusions can be drawn due to very
clear differences between human and animal skin immunology. Forarboxyﬂuorescein succinimidyl
ll sorting; FCS, fetal calf serum;
rmatitis; KC, keratinocytes; LC,
ns Cell; NiSO4, nickel sulfate
rophyll protein; SDS, sodium
ctor beta; TNF-α, tumor necrosis
ology (Room 11N69) Academic
Z Amsterdam, The Netherlands.
. This is an open access article underexample, murine TLR4 does notmediate a response to themost common
human sensitizer nickel, whereas in man TLR4 plays a crucial role in
elicitation of an allergic response to nickel (Schmidt et al., 2010). Indeed
extensive phenotypic and functional differences have been reported
between human and mouse dendritic cell (DC) subsets (Shortman and
Liu, 2002; van de Ven et al., 2011a). Furthermore, there is an increasing
drive within Europe to reﬁne, reduce and to replace test animals with
in vitro alternatives wherever possible (Adler et al., 2011).
In order to investigate DC biology, in particular in the area of human
safety and risk assessment of chemicals, and for testing novel drugs and
therapeutic strategies a number of in vitromodels have been proposed.
Fresh human skin explants provide a very relevant model to study
Langerhans cell (LC) biology in situ (Ouwehand et al., 2008, Ouwehand
et al., 2010a; Jacobs et al., 2006; Lindenberg et al., 2013; Oosterhoff
et al., 2013). However, the use of skin explants for research purposes
and in vitro diagnostic assays requires a steady supply of large amounts
of freshly excised skin, which creates a logistical bottleneck and can intro-
duce high donor variation. To avoid the use of explant material, cultured,the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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lines, either human or animal-derived) have been extensively studied
(dos Santos et al., 2009). A limitation in using these DC cultures is that
they lack interactions with other cell types (e.g. keratinocytes and ﬁbro-
blasts) which are essential for promoting in vivo-like DC maturation and
migration. Furthermore, the skin barrier (stratum corneum) is absent. In
order to overcome the absence of the skin barrier, the group of Schmidt
incorporated cord blood-derived LC into human epidermis reconstructed
fromprimary keratinocytes (Facy et al., 2005; Regnier et al., 1997).Wide-
spread implementation of this model is limited however by its depen-
dence on fresh cord blood which creates a major logistical problem as
well as donor variation. Furthermore the dermal component is absent
which is essential for the regulation of LC migration from the epidermis
(Ouwehand et al., 2008, Ouwehand et al., 2010a). Previously we have de-
scribed a full-thickness skin equivalent (SE) composed of a reconstructed
epidermis on a ﬁbroblast populated collagen gel (Spiekstra et al., 2005).
Since it was not possible to distinguish allergens from irritants in this
model by assessing increases in cytokine secretion, we next proceeded
to incorporate LC into this in vitro SE model (Ouwehand et al., 2011b,
Ouwehand et al., 2012).
The human Acute Myeloid Leukemia (AML) cell line MUTZ-3 was
used for incorporation into SE. This cell line can be differentiated in a
Transforming Growth Factor (TGF)-β-dependent fashion into LC
(MUTZ-LC), expressing Langerin and bearing LC-associated Birbeck gran-
ules (Masterson et al., 2002; Santegoets et al., 2006). In mono-culture,
upon stimulation with maturation inducing factors (including allergens),
MUTZ-LC expressed characteristic maturation markers, such as CD83,
CXCR4 and CCR7, and acquired the ability to migrate towards CXCL12,
thus closely resembling their in vivo counterparts (Larsson et al., 2006;
Ouwehand et al., 2008, Ouwehand et al., 2010b). When MUTZ-LC were
incorporated into full-thickness SE they showed the ability to mature
and migrate from the epidermis into the dermis after topical exposure
of the stratum corneum to the allergens nickel sulfate and resorcinol
(Ouwehand et al., 2011b).
Previously we have shown in fresh skin explant cultures that topical
allergen and irritant exposure both result in LCmigration, butmediated
through different dermis-derived chemokines, i.e. CXCL12 (Ouwehand
et al., 2008; Spiekstra et al., 2005) and CCL2/CCL5 (Ouwehand et al.,
2010a), respectively. Whereas allergen-induced migration is accompa-
nied by LC maturation and CXCR4 up-regulation, irritant-induced
migration results in an intradermal LC-to-macrophage phenotypic
switch by down-regulation of surface expression of Langerin and CD1a
and up-regulation of CD14 surface expression and cytoplasmic CD68,
in an IL-10 dependent fashion (de Gruijl et al., 2006; Ouwehand et al.,
2011a). Even though the ex-vivo skin explant model is clearly a valuable
tool to study DC biology, it is greatly limited by logistics as mentioned
above. But importantly since the skin is a complex organ containing
many different cell types and precursors it is difﬁcult to pin-point a
phenotypic change within the tissue context exactly to a particular
cell type. It cannot be entirely ruled out that the macrophage-like cells
identiﬁed within the dermis after irritant exposure may also be derived
from another cell type present in the skin biopsy.
In this studywe show that the SE-LCmodel is themost physiologically
relevant human SE model known to date in that all DC biology events
described above for healthy human skin explants could be reproduced
in this in vitro tissue engineered model. As such it provides an excellent
tool to investigate skin biology in a controlled and fully deﬁned manner.
Materials & methods
Cell culture
Human skin explants: explants were obtained after informed consent
from patients undergoing corrective breast or abdominal plastic surgery
and used in an anonymous fashion in accordance with the “Code for
Proper Use of Human Tissues” as formulated by the Dutch Federation ofMedical Scientiﬁc Organizations (www.fmwv.nl) and following
procedures approved by the institutional review board of the VU
University Medical Center.
Epidermal keratinocytes and dermal ﬁbroblasts: cells were isolated
and cultured as described previously (Kroeze et al., 2012; Ouwehand
et al., 2011b).
MUTZ-3 cell line: the MUTZ-3 progenitor cell line (Deutsche
Sammlung von Mikroorganismen und Zellkulturen [DSMZ],
Braunschweig, Germany) was maintained as previously described by
Masterson et al. (Masterson et al., 2002). MUTZ-3 progenitor cells were
differentiated into LC by culturing at 2 × 105 cell/mL inminimal essential
media (MEM)-alpha (Gibco, Grand Island, NY, USA) supplemented with
20% v/v heat inactivated fetal calf serum (Hyclone Laboratories, Logan,
UT, USA), 1% penicillin-streptomycin, 2 mM L-glutamine (Gibco), 50 μM
2-β mercaptoethanol (Merck, Whitehouse Station, NY), 100 ng/mL
recombinant human granulocyte macrophage-colony stimulating factor
(Biosource, International Inc, Camarillo, CA, USA), 10 ng/mL
TGF-β (Biovision, Mountain View, CA, USA) and 2.5 ng/mL TNF-α
(StrathmannBiotec, Hamburg, Germany) over a period of 7 days. Cells
were cultured at 37 °C, 5% CO2, 95% humidity. MUTZ-LC were labeled
with carboxyﬂuorescein succinimidyl ester (CFSE) as describedpreviously
(Ouwehand et al., 2010b).
Construction of SE-LC: Hydrated collagen gels were prepared, as
described by Smola et al. (1993) using 4 mg/mL collagen solution
isolated from rat-tails. Brieﬂy, the collagen solution was mixed
at 4 °C with a ﬁbroblast suspension to reach a ﬁnal density of
0.8 × 105 cells/mL. Next, 2 mL of collagen suspension was pipetted
onto a ﬁlter insert (six wells plate, 3450 Corning Costar, NY). After
1.5 h of incubation at 37 °C in a humidiﬁed atmosphere containing
5% CO2 to allow gel polymerization, 8 mL of culture medium was
added and the collagen matrices were subsequently incubated for
24 h. Construction of the human SE containing MUTZ-LC (SE-LC)
was achieved by co-seeding CFSE labeled MUTZ-LC (1 × 106 cells)
with KC (0.5 × 106 cells) onto ﬁbroblast-populated collagen gels
essentially as previously described (Ouwehand et al., 2011b) followed
by culturing for 4 days submerged and then 7 days at an air–liquid
interface before chemical exposure. Unless otherwise stated, all additives
were purchased from Sigma Chemical Co. (St. Louis, MO, USA). For
blocking experiments 7 μg/mL goat anti-human CXCL12 (AF-310-NA,
R&D systems, Minneopolis, MN, USA), 7 μg/mL goat anti-human CCL5
(AF-278-NA, R&D systems) or 2 μg/mL goat anti-human IL-10 (AF-217-
NA, R&D systems) was added to the culture medium prior to chemical
exposure (optimal blocking concentration was previously determined)
(Ouwehand et al., 2008, 2010a, 2011a). Isotype control to assess
non-speciﬁc reactions was added at 7 μg/mL polyclonal goat IgG
(6-001-F, R&D systems).
Irritant or allergen exposure: Finn Chamber ﬁlter paper disks
of 11 mm diameter (Epitest, Oy, Finland) were impregnated with
vehicle (H2O), allergens (nickel sulfate hexahydrate (NiSO4·6H2O),
cinnamaldehyde or resorcinol (Sigma Chemical Co.)), or irritants
(Tween 80, Triton X-100 or SDS), dissolved in H2O as previously
described (Gibbs et al., 2013). Chemical or vehicle impregnated
disks were applied topically to the stratum corneum of SE-LC cultures
for 16 h at 37 °C, 7.5% CO2.
Immunohistochemical staining. Fromparafﬁn embedded full-thickness
human skin and in vitro cultured SE-LC, 5 μmtissue sectionswere cut. The
sections were deparafﬁnized and rehydrated in preparation for morpho-
logical (hematoxylin–eosin staining) or immunohistochemical analysis
which was performed as previously described (Ouwehand et al., 2008,
2010a). In brief, antigen-retrieval was performed using citrate buffer
and after cooling incubated overnight at room temperature with primary
monoclonal antibody directed against HLA-DR (mouse IgG1 clone
TAL.1B5, Dako, Denmark). Sections were incubated for another 30 min
with human anti-mouse conjugated to horse radish peroxidase after
washing with PBS. Subsequently, the slides were incubated for 10 min
Fig. 1.Human full thickness skin equivalentwithMUTZ-LC. A) Phenotypic characterizationof
MUTZ-LC after 7 days of differentiation. Flow cytometry dot plots show HLA-DR, CD1a,
Langerin positive cells and double positive cells; percentage positive cells is written in the
quadrants. B) Histology (hematoxylin–eosin staining) of SE-LC (200× magniﬁcation; scale
bar represents 50 μm). C) HLA-DR immunohistochemical staining of MUTZ-LC in SE-LC
(200× magniﬁcation; scale bar represents 50 μm). D) CFSE staining of the epidermal sheet
isolated from SE-LC (100×magniﬁcation). Representative photographs from 5 independent
experiments are shown.
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counter-stained with hematoxylin. Negative controls were prepared by
omitting the primary antibody and substituting an isotype control
antibody. The sectionswere embedded in Aquatex® (Merck,Whitehouse
Station, NJ, USA).
Quantitation of MUTZ-LC in epithelial sheets. After allergen exposure,
the epithelial sheets were harvested by separating the ﬁbroblast popu-
lated collagen gel from the epithelial sheet with ﬁne forceps. The densi-
ty of LC in the epidermal sheets was determined by incubating the
sheets for at least 1 h (max. overnight) with 50 μl/mL PE-labeled anti-
CD1a (BD Pharmingen, San Diego, CA) in FACS buffer. Subsequently,
the epidermal sheetswerewashed three times in PBS and then examined
using a ﬂuorescence microscope (Nikon Eclipse 80i, G-2a Ex510-560,
DM575, BA590). The density of CD1a+ LC was calculated by determining
themeasured ﬂuorescence indexwith Image J software and expressed as
CD1a ﬂuorescence intensity.
Flow cytometry. MUTZ-LC migration from the epidermis of SE was
assessed by ﬂow cytometry. Cell staining was performed using
mouse anti-human CD1a-PE (IgG1, BD pharmingen, San Diego, CA,
USA), mouse anti-human CD14-FITC/PerCP (IgG2a, Miltenyi Biotec,
BergischGladbach, Germany), intracellular CD68-PE (kit 556078,
IgG2b κ, BD pharmigen). Isotype controls to assess non-speciﬁc binding
were mouse IgG1-PE, IgG2b κ (BD pharmingen) and mouse IgG2a-FITC
(MiltenyiBiotec). Additionally, a staining with propidium iodine (Gibco)
was performed to conﬁrm the viability of the migrated LC. Cells were
washed in PBS containing 0.1% BSA and 0.1% sodium azide, incubated
with antibodies for 30 min and resuspended in the same buffer for FACS
analysis on a FACScalibur ﬂow cytometer (Beckton Dickinson, San Jose,
CA, USA). The data were subsequently analyzed using CellQuestPro
software.
Quantitation of MUTZ-LC in dermal compartments. In order to isolate
cells (ﬁbroblasts and MUTZ-LC) from within the collagen gel, gels
were digested with 1% collagenase type II (Gibco) in Hanks buffered salt
solution (Gibco) for 15 min at 37 °C. An excess amount of Flow-Count
ﬂuorospheres (Beckman Coulter, Fullerton, CA, USA) was added to the
harvested cells and these were then stained with mouse anti-human
CD1a-PE, mouse anti-human CD14-FITC or CD14-PerCP, or intracellular
CD68-PE (kit 556078, IgG2b κ, BD pharmigen) before analysis with a
FACScalibur ﬂow cytometer (Beckton Dickinson, San Jose, CA, USA). The
data were subsequently analyzed using CellQuestPro software.
Real-time PCR. Epidermis was removed from the dermis using ﬁne
forceps. Total RNA was isolated from the dermis and RT-PCR analysis
was performed as described previously (Ouwehand et al., 2011b). cDNA
was ampliﬁed by PCR using the following primer kits: RT2 qPCR Primer
Assay for Human CD68 and as housekeeping genes RT2 qPCR Primer
Assay for Human HPRT and RT2 qPCR Primer Assay for Human GAPDH.
Statistical analysis. Statistical analysis of the number of LC under
the different experimental conditions was performed using unpaired
Student's t-test or Mann–Whitney tests by GraphPad Prism version 6.00
for Windows, (GraphPad Software, La Jolla California USA). Differences
were considered signiﬁcant when P b 0.05.
Results
Differential chemokine dependence of epidermis-to-dermis MUTZ-LC
migration in SE after topical exposure to allergens versus irritants
In order to investigate LC migration from the epidermis to the
dermis, partially differentiated MUTZ-3 derived LC with low levels of
CD1a, Langerin and HLA-DR (Fig. 1A) were co-seeded with humanskin KC onto a ﬁbroblast populated collagen gel. The SE containing
MUTZ-LC closely resembled nativehuman skin. It consisted of a fully dif-
ferentiated epidermis reconstructed on a ﬁbroblast populated collagen
gel (Fig. 1B). The epidermis had a compact basal layer of keratinocytes,
a spinous layer, granular layer and stratum corneum. MUTZ-LC were
dispersed evenly throughout the 3D architecture of the epidermis and
also at the epidermal–dermal junction (Figs. 1C and D). The model has
been described in detail previously (Ouwehand et al., 2011b). In this
study, we further tested the functionality of the SE-LC model by topically
exposing SE-LC to a panel of allergens and irritants.
First, epidermis-to-dermismigration ofMUTZ-LC in SEwas investigat-
ed after exposure to chemical allergens. After topical exposure to NiSO4
(10 mM), MUTZ-LC migrated out of the epidermis. This is demonstrated
by the absence of CD1a+MUTZ-LC in epidermal sheets after NiSO4 expo-
sure compared to the presence of CD1a+ MUTZ-LC in unexposed and
vehicle exposed epidermal sheets (Fig. 2A). To assess CXCL12dependence
of allergen-induced MUTZ-LC migration from the epidermis the culture
medium was supplemented with a neutralizing antibody against
CXCL12 during chemical exposure. Indeed, conﬁrming our previous
Fig. 2.MUTZ-LC migration out of the epidermis after allergen but not irritant exposure is
CXCL12 dependent. A) Epidermal sheets isolated from SE-LC and stained with anti-CD1a-
PE are shown. SE-LC were unexposed, water vehicle exposed or exposed to 10 mM NiSO4
or 2.5 mM Triton X-100 for 16 h in the presence of the neutralizing antibody to CXCL12 or
IgG1 isotype control as described in Materials & methods. Fluorescence intensity (white)
shows presence or absence of MUTZ-LC in epidermal sheets. B) SE-LC were unexposed (U),
exposed to water vehicle (V), or allergens (10 mM NiSO4, 15 mM resorcinol, 1 mM
cinnamaldehyde) or C) irritants (2.5 mM Triton X-100, 0.5 mM Tween 80, 5 mM SDS) for
16 h. Chemical exposure was performed in the presence of the neutralizing antibody to
CXCL12 (+) or IgG1 isotype control (−). CD1a-PE ﬂuorescence intensity of MUTZ-LC in
epidermal sheets was quantiﬁed using Image J software. Data represent the average of 5
individual experiments performed in duplicate ± SEM. *p b 0.05, **p b 0.01 was calculated
using the Mann–Whitney t-test.
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the SE-LC, incubation with anti-CXCL12 completely blocked NiSO4
induced MUTZ-LC migration from the epidermis (Figs. 2A and B).
The pivotal role of CXCL12 in mediating epidermis-to-dermis migration
of MUTZ-LC upon allergen exposure was further conﬁrmed for the
allergens resorcinol and cinnamaldehyde (Fig. 2B).
After topical exposure of SE-LC to irritants (Triton X-100, Tween 80,
SDS), CD1a+MUTZ-LCmigrated out of the epidermal sheets similarly to
allergen-exposed LC (Figs. 2A and C). Whereas incubation with the
neutralizing antibody to CXCL12 failed to inhibit this irritant-induced
migration from the epidermis, incubation with anti-CCL5 completely
inhibitedmigration (Figs. 2A,C and Fig. 3). In contrast,MUTZ-LCmigration
after exposure to the allergen NiSO4 was not inhibited by anti-CCL5
(Fig. 3).
Increased CD14 and CD68 expression and decreased CD1a surface levels on
MUTZ-LC during irritant-induced epidermis-to-dermis migration
Next, the phenotype of the migrated MUTZ-LC was investigated. To
this end, the isolated dermal compartments were digested and, upon
live gating by forward and side scatter properties, migrated LC were
analyzed by ﬂow cytometry. Whereas an increase in CD1a+ MUTZ-LC
rateswere observed in the collagen gel (dermis) after allergen exposure
(control: 2%; vehicle: 4%; NiSO4: 65%), no corresponding increase in
CD1a+ MUTZ-LC were detected in the collagen gels after irritant Triton
X-100 exposure (Fig. 4). In order to determine whether the post-
migrationMUTZ-LCwere indeed still viable and detectable after irritant
exposure, MUTZ-LC were labeled with CFSE before incorporating into
SE. In contrast to unexposed or vehicle exposed SE-LC, after topical
exposure to Triton X-100, CFSE labeled MUTZ-LC were clearly detected
in the collagen gel proving that viable MUTZ-LC had indeed actively
migrated from the epidermis-to-dermis upon irritant exposure
(Fig. 5A). In order to determinewhetherMUTZ-LCwere able to undergo
a phenotypic switch to amacrophage-like state after irritant exposure, in
line with their primary counterparts in native skin explants (de Gruijl
et al., 2006; Ouwehand et al., 2011a), cells isolated from the collagen
gels were stained with antibodies for CD14 or RNA was isolated for
PCR with CD68 primers. After irritant exposure a clear increase in
CD14+ cells (Figs. 5B and C) and also an increase in CD68 transcripts
(Fig. 5D) were detected in the collagen gels. This was not detected in
the NiSO4 exposed collagen gels (Fig. 5D). We therefore conclude that,
after irritant exposure, MUTZ-LC in SE-LC are able to undergo a pheno-
typic switch to a macrophage-like state as shown by decreased CD1a
and increased CD14 and CD68 expression during epidermis-to-dermis
migration.
MUTZ-LC irritant-induced phenotypic switch from CD1a+ LC to
CD14+/CD68+ macrophage-like cells is IL-10 dependent
In the skin explant model we have previously shown that the
irritant-induced LC-to-macrophage switch was dependent on IL-10
(Ouwehand et al., 2011a). In order to determine whether MUTZ-LC
could also show this degree of plasticity SE-LC were incubated with
neutralizing antibodies to IL-10 during irritant exposure (Triton
X-100). Whereas anti-IL-10 had no effect on irritant mediated
MUTZ-LC migration from the epidermis to the dermis (Fig. 6A), the
increase in CD1a−/CD14+/CD68+ MUTZ cells accumulating in the
dermis was totally inhibited by anti-IL-10 (Fig. 6B).
Discussion
In this studywe provide novel and further evidence that theMUTZ-3
cell line is themost physiologically relevant LC-like cell line identiﬁed to
date since it shows a unique in vivo like plasticity upon exposure to
environmental stimuli (e.g. allergens, irritants). In the past we showed
thatMUTZ-3were able to differentiate in a cytokine dependent manner
Fig. 3.MUTZ-LC migration out of the epidermis after irritant but not allergen exposure is
CCL5 dependent. SE-LC were exposed to water vehicle (V), 10 mM NiSO4 (N) or 2.5 mM
Triton X-100 (T) for 16 h. Chemical exposure was performed in the presence of the
neutralizing antibody to CCL5 (+) or IgG1 isotype control (−). Number of CD1a-PE positive
MUTZ-LC in epidermal sheets was quantiﬁed using Image J software. Data represent the
average of 4 individual experiments ± SEM. *p b 0.05, **p b 0.01 was calculated using the
Mann–Whitney t-test.
Fig. 4.MUTZ-LC migrating into the dermis are CD1a positive after allergen exposure but
CD1a negative after irritant exposure. CD1a-PE ﬂow cytometric staining of MUTZ-LC
isolated from the dermal matrix (collagen gel) after allergen NiSO4 or irritant Triton
X-100 exposure in the presence of neutralizing antibodies to CXCL12 (+) or IgG1 isotype
control (−). A) ﬂow cytometry dot plots of CD1a-PE positive MUTZ-LC; percentage positive
cells arewritten in theupper right corner. B) Percentage of CD1a+MUTZ-LC indermalmatrix
was quantiﬁed by ﬂow cytometry using Flow-Count ﬂuorospheres and CD1a-PE label. Data
represent the average of 5 experiments performed in duplicate ± SEM. *p b 0.05,
**p b 0.01 was calculated using the Mann–Whitney t-test.
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(Masterson et al., 2002; van de Ven et al., 2011b), which are both able
to prime speciﬁc T cell responses (Santegoets et al., 2006; Santegoets
et al., 2008). Here we show that upon topical allergen exposure epider-
mal MUTZ-LC mature and migrate in a CXCL12 dependent, and CCL5
independent, manner to the dermal compartment of SE, whereas after
topical irritant exposure they migrate in a CCL5 dependent, and CXCL12
independent, manner and undergo an IL-10 dependent phenotypic
change to a macrophage-like cell within the dermal compartment.
The SE-LC was designed to enable complex mechanisms concerning
human DC biology to be investigated in an animal alternative, physio-
logically relevant test model. Whereas sensitization after allergen
exposure (leading eventually to allergic contact dermatitis (ACD)) has
been extensively described in the literature e.g. penetration of
chemicals through the stratum corneum, activation of keratinocytes,
maturation and migration of LC to the draining lymph nodes and
stimulation of T cell responses (Roggen, 2014), extremely little is
known about the mechanisms resulting in irritant contact dermatitis
(ICD). Clearly, a localized acute inﬂammatory reaction is involved.
Furthermore, it has been shown that the number of CD1a positive
cells decreases in both the epidermis and dermis in ICD (Jacobs et al.,
2006; Marks et al., 1987). Until now, the fate of these migrated LC was
unknown. Previously we have shown using the explant skin model
that irritant exposure resulted in a decrease in CD1a+ cells in the
epidermis and an increase in CD14+/CD68+ cells in the dermis indicative
of a phenotypic switch of LC to macrophage-like cells (de Gruijl et al.,
2006; Ouwehand et al., 2011a). Since the SE-LC is a fully deﬁned skin
system, and contains no confounders such as unknown inﬁltrating
(precursor) cells e.g. locally proliferative monocytes and since
MUTZ-LC were labeled with CFSE before incorporating into the
SE-LC, we can now unambiguously demonstrate that LC undergo a
phenotypic trans-differentiation into macrophage-like cells uponirritant exposure. This alternative end-stage differentiation of LC to
CD14+/CD68+ macrophage-like cells could play an important role
in rapidly removing damaged skin tissue after e.g. skin irritancy,
UV radiation, and during wound healing, thus playing a key role in
maintaining immunological ignorance and avoiding the generation of
collateral autoimmunity. Our ﬁnding that anti-inﬂammatory cytokine
40 I.J. Kosten et al. / Toxicology and Applied Pharmacology 287 (2015) 35–42IL-10 is responsible for the post-migrational switch of LC into
a macrophage-like cell upon irritant exposure is fully in line with our
previous ex vivo skin explant studies (de Gruijl et al., 2006; Ouwehand
et al., 2011a).Fig. 5.MUTZ-LC migrating into the dermis after irritant exposure are CD14+/CD68+.A.)
Increased numbers of viable CSFE labeled MUTZ-LC are detected by ﬂow cytometry in the
dermal matrix after irritant Triton X-100 exposure compared to unexposed or water vehicle
exposed SE-LC. B) Dot plots of ﬂow cytometric staining show CD14 positive MUTZ-LC in the
dermal matrix (collagen gel) after irritant (2.5 mM TritonX-100, 0.5 mM Tween 80)
exposure. Percentage positive cells written in the upper right corner. C) The relative number
of CD14 positive MUTZ-LC in dermal matrix compared to unexposed SE-LC was detected by
ﬂow cytometry and quantiﬁed using Flow-Count ﬂuorospheres. D) RT-PCR shows increased
number of CD68 transcripts in dermis after irritant (2.5 mM TX-100, 5 mM SDS) or allergen
NiSO4 exposure (10 mM). For C) and D) U = unexposed; V = vehicle exposed;
TX-100 = Triton X-100; and T 80 = Tween 80. Data represent the average of at least 4
individual experiments±SEM. *pb 0.05, **p b 0.01was calculated using theMann–Whitney
t-test.A limited number of epidermal equivalent models (Facy et al., 2005;
Regnier et al., 1997; Schaerli et al., 2005), dermal equivalent models
(Guironnet et al., 2001) and full-thickness SE models (Bechetoille
et al., 2007; Dezutter-Dambuyant et al., 2006; Uchino et al., 2009)
have been described with integrated LC or DC. Moreover all of these
models are reliant on fresh blood-derived precursor cells for their
source of LC or DC. This introduces extremely difﬁcult logistics in
ﬁne-tuning the timely arrival of blood (LC or DC source) and skin tissue
(primary keratinocyte and ﬁbroblast source) to the laboratory, and
ﬁne-tuning the culture of the different cell types in order to have all
cells ready to construct the skin model on the same day. A number of
the epidermal equivalent models have been used to investigate LC
responses to chemical sensitizers. However, as the ﬁbroblast-populated
dermis is absent, the LC do not migrate and only a limited number of LC
maturation state changes have been reported. (e.g. increased CCR7,
CD86 expression or different cytokine secretions) (Facy et al., 2005;
Regnier et al., 1997; Schaerli et al., 2005). We have previously shown
that topical exposure of our SE-LC to allergens results inMUTZ-LC starting
to mature in the epidermis (increased IL-1β) and migrating from the
epidermis to the dermis where they further up-regulate CCR7 and CD83
(Ouwehand et al., 2011b). Now we show that similarly to excised skin,
this allergen and ﬁbroblast-dependent MUTZ-LC migration can be
completely blocked by a neutralizing antibody to CXCL12. The SE-LC is
the only in vitromodel to date that enables this degree of LC biology to
be explored after allergen exposure of the skin and therefore it provides
an alternative means to identify pathogenic sensitizers which are giving
ambiguous results in other test models. Furthermore, since chemicals
are applied topically to the stratum corneum the SE-LC can be used to
test water insoluble chemicals.
The phenotypic change of LC to a macrophage-like cell is not only
conﬁned to irritancy. We and others have reported the existence of an
inter-related population of cutaneous DC and macrophages in ﬂux,
trans-differentiating into each other in response to environmental
stimuli (de Gruijl et al., 2006; Diao et al., 2012; Ouwehand et al.,
2011a). This ﬁnding has direct consequences for the type of immune
responses that will follow, as different migratory DC sub-populations
have now been directly linked to the induction of different types of
immunity (Lindenberg et al., 2013). For example, CD1a+ mature LC
and dermal DC subsets have been linked to type-1 T cell mediated
immunity, whereas CD14+ immature dermal DC subsets have been
linked to the induction of humoral immunity and expansion of regulatory
T cells (Treg) (Banchereau et al., 2012; Chu et al., 2012). Further research
will determine to what extent the full thickness SE-LC model will be able
to replace animal tests for skin-based immunization studies, other
pharmaceutical testing and even for incorporation into organ-on-a-chip
models with future application in personalized medicine strategies
(Huh et al., 2010).
In this studywe have illustrated with the aid of allergens and irritants
that MUTZ-LC integrated in the SE-LC are fully functional and that,
depending on environmental danger or damage associated signals,
MUTZ-LC will migrate and mature, or migrate and undergo a phenotypic
change into a macrophage-like cell. From our ﬁndings we conclude that
the SE-LC is most suitable for chemical hazard identiﬁcation. Since the
Fig. 6.MUTZ-LC phenotypic switch from CD1a+ to CD1a−/CD14+/CD68+ cells is IL-10
dependent. SE-LCwereunexposed (U), exposed towater vehicle (V), or 2.5mMTritonX-100
(T) for 16 h. Chemical exposure was performed in the presence of the neutralizing antibody
to IL-10 (+) or IgG1 isotype control (−). A) CD1a-PE positiveMUTZ-LC in epidermal sheets.
B) The relative number of CD14+/CD68+CFSE labeled cells compared to IgG1unexposed SE-
LCwere detected by ﬂow cytometry in the dermalmatrix. Unexposed (U), exposed towater
vehicle (V), 10 mM NiSO4 (N), and 2.5 mM Triton X-100 (T). Data represent 5 individual
experiments ± SEM. *p b 0.05, **p b 0.01 was calculated using the Mann–Whitney t-test.
41I.J. Kosten et al. / Toxicology and Applied Pharmacology 287 (2015) 35–42read-out consists of physiologically relevant functional changes in LC
behavior, it provides an alternative method in particular for the testing
of chemical allergens and irritants which are difﬁcult to distinguish from
each other. This alsomakes themodel suitable for awide range of studies
not just including hazard identiﬁcation but also for investigating DC
biology under normal steady-state conditions or in skin diseases and
in particular cancer. It will enable vaccination research to occur in a
standardized humanmodel which in turn will lead to the identiﬁcation
of novel drug targets and therapeutic strategies.
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